메뉴 건너뛰기




Volumn 33, Issue 3, 2011, Pages 190-192

The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; CYCLOPHOSPHAMIDE; DIACYLGLYCEROL; DOXORUBICIN; FLUOROURACIL; GLUCOSE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; SPHYNGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 80053392648     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (9)
  • 1
    • 33947653911 scopus 로고    scopus 로고
    • The metabolic syndrome: A high-risk state for cancer?
    • DOI 10.2353/ajpath.2006.051090
    • Cowey S, Hardy R. The metabolic syndrome. A highrisk state for cancer? Am J Pathol 2006; 169: 1505-22. (Pubitemid 351181984)
    • (2006) American Journal of Pathology , vol.169 , Issue.5 , pp. 1505-1522
    • Cowey, S.1    Hardy, R.W.2
  • 2
    • 77950848588 scopus 로고    scopus 로고
    • Metabolic syndrome and endometrial carcinoma
    • Bjørge T, Stocks T, Lukanova A, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2009; 171: 892-902.
    • (2009) Am J Epidemiol , vol.171 , pp. 892-902
    • Bjørge, T.1    Stocks, T.2    Lukanova, A.3
  • 3
    • 40349085518 scopus 로고    scopus 로고
    • Obesity, metabolic syndrome, and prostate cancer
    • Hsing AW, Sakoda LC, Chua B. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007; 86: 843-57.
    • (2007) Am J Clin Nutr , vol.86 , pp. 843-857
    • Hsing, A.W.1    Sakoda, L.C.2    Chua, B.3
  • 4
    • 77954528680 scopus 로고    scopus 로고
    • Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) project
    • Bjørge T, Lukanova A, Jonsson H, et al. Metabolic syndrome and breast cancer in the Me-Can (Metabolic Syndrome and Cancer) project. Cancer Epidemiology, Biomarkers &Prevention 2010; 19: 1737-45.
    • (2010) Cancer Epidemiology, Biomarkers & Prevention , vol.19 , pp. 1737-1745
    • Bjørge, T.1    Lukanova, A.2    Jonsson, H.3
  • 5
    • 67049119417 scopus 로고    scopus 로고
    • Serum lipids profile of breast cancer patients
    • Owiredu W, Donkor S, Addai B. Serum lipids profile of breast cancer patients. Pak J Biol Sci 2009; 12: 332-8.
    • (2009) Pak J Biol Sci , vol.12 , pp. 332-338
    • Owiredu, W.1    Donkor, S.2    Addai, B.3
  • 6
    • 39049114042 scopus 로고    scopus 로고
    • Significance of alterations in plasma lipid profile levels in breast cancer
    • March
    • Shah FD, Shukla SN, Shah PM, et al. Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther March 2008; 7: 332-4.
    • (2008) Integr Cancer Ther , vol.7 , pp. 332-334
    • Shah, F.D.1    Shukla, S.N.2    Shah, P.M.3
  • 8
    • 0035106437 scopus 로고    scopus 로고
    • Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: A prospective study within the Malmö Preventive Project
    • DOI 10.1097/00008469-200102000-00004
    • Manjer J, Kaaks R, Riboli E, Berglund G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the MalmöPreventive Project. Eur J Cancer Prev 2001; 10: 33-42. (Pubitemid 32200200)
    • (2001) European Journal of Cancer Prevention , vol.10 , Issue.1 , pp. 33-42
    • Manjer, J.1    Kaaks, R.2    Riboli, E.3    Berglund, G.4
  • 9
    • 0028097588 scopus 로고
    • Risk of breast cancer in relation to blood lipids: A prospective study of 31,209 Norwegian women
    • DOI 10.1007/BF01831377
    • Gaard M, Tretli S, Urdal P. Risk of breast cancer in relation to blood-lipids - a prospective study of 31209 Norwegian women. Cancer Causes Control 1994; 5: 501-9. (Pubitemid 24335712)
    • (1994) Cancer Causes and Control , vol.5 , Issue.6 , pp. 501-509
    • Gaard, M.1    Tretli, S.2    Urdal, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.